Platform Unit 4. Preclinical Validation: Bioimaging
You are here : Home / Platform Unit 4. Preclinical Validation: Bioimaging
Platform Unit 4 give support in the preclinical developmente of new therapeutic compounds by validating new therapeutic targets and/or nanotherapies by using optical image techniques and NMR.
Some of the funtcions of this platfor are:
Analysis of fagocytic behavior and interactions of cells in poresence of magnetic nanoparticled therapeutic agents.
Spectroscopies for ain vivo applications and for apllications in biofluids, tissues and biomaterials.
In vivo Validation, visualization and quantification of therapeutic agents tested and visualization and quantification of the induced tissue regeneration at real time.
Validation of new therapeutic targets.
In vivo Validation, visualization and quantification of celular and genetic activities dealing with pathologies at real time.